Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Supriya Koya"'
Publikováno v:
Cureus.
A Case of De Novo Psoriasis Secondary to Nivolumab in a Patient With Metastatic Renal Cell Carcinoma
Publikováno v:
Cureus
Immune-mediated adverse events are commonly seen with immune checkpoint inhibitors like nivolumab. Oncology specialists usually have to screen patients for risk factors for autoimmune diseases, since immune checkpoint inhibitors can potentially exace
Publikováno v:
Medical Science Case Reports. 3:28-31
Publikováno v:
Baylor University Medical Center Proceedings. 31:227-228
Vitamin C deficiency may be common in third-world countries due to malnutrition, but it is currently rare in the USA. Initially, nonspecific symptoms like exhaustion and depression may make this disease difficult to diagnose until classical dermatolo
Publikováno v:
World Journal of Oncology
Langerhans cell histiocytosis (LCH) is a rare disorder most commonly seen in Caucasians of Northern European decent, male, children. The most common presentation is osteolytic bone lesions. A 44-year-old native American presents with diffuse erythema
Publikováno v:
Clinical Pulmonary Medicine. 14:368-371
Publikováno v:
Current Colorectal Cancer Reports. 5:179-181
Publikováno v:
Journal of General Internal Medicine
We describe a 59-year-old patient who developed acute renal failure because of rhabdomyolysis after extensive red fire ant bites. This case illustrates a serious systemic reaction that may occur from fire ant bites. Consistent with the clinical prese
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 44(11)
Autor:
Alan B. Cantor, Randall S. Davis, Francisco Robert, Vishnu Reddy, Supriya Koya, Fun Jun Li, Ravi Kumar Paluri
Publikováno v:
Blood. 116:4624-4624
Abstract 4624 Background: Identifying prognostic markers is important for clinical and pathological course of chronic lymphocytic leukemia. Percentage of smudge cells in CLL patients has recently been reported as a novel prognostic factor. We present